Antioxidant effect of immediate- versus sustained-release melatonin in type 2 diabetes mellitus and healthy controls
- 28 May 2014
- journal article
- Published by Taylor & Francis Ltd in Drug Delivery
- Vol. 23 (3), 804-807
- https://doi.org/10.3109/10717544.2014.917343
Abstract
Oxidative damage has been suggested as the primary cause of aging and age-associated diseases including type 2-dependent diabetes mellitus (T2DM) and therefore there is a growing interest in exploring therapeutic potential of antioxidant agents including melatonin. In the present study, we analyzed red blood cell antioxidants and lipid peroxidation after 5 mg/daily immediate-release melatonin treatment of elderly T2DM patients and healthy elderly subjects in comparison with 2 mg/daily sustained-release melatonin treatment of elderly T2DM patients and healthy elderly subjects, to determine the antioxidant effect of different doses and formulations of melatonin in these groups. Our study revealed that there was no significant difference in antioxidant status of red blood cells measured by glutathione concentration and activities of GPx-1, CAT, GR, SOD-1 and MDA levels, after supplementation with 2 mg-sustained release melatonin or with 5 mg-immediate release melatonin, either in T2DM or in healthy elderly subjects. These results suggest that both preparations may exert similar therapeutic effect related to melatonin's action on antioxidant defense system.Keywords
This publication has 18 references indexed in Scilit:
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep DisordersPLOS ONE, 2013
- Melatonin protects against isoproterenol‐induced myocardial injury in the rat: antioxidative mechanismsJournal of Pineal Research, 2010
- Reactive Oxygen Species Enhance Insulin SensitivityCell Metabolism, 2009
- Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertensionJournal of Pineal Research, 2009
- Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetesJournal of Pineal Research, 2008
- Prolonged-release melatonin for the treatment of insomnia in patients over 55 yearsExpert Opinion on Investigational Drugs, 2008
- Melatonin as a potential antihypertensive treatmentJournal of Pineal Research, 2007
- The Use of Vitamin E in Type 2 Diabetes MellitusClinical and Experimental Hypertension, 2007
- Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complicationsAnnals of Medicine, 2005
- Physiological levels of melatonin contribute to the antioxidant capacity of human serumJournal of Pineal Research, 1999